US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

4.30

+0.600016.22%

Post-market: 4.300.00000.00%19:45 EDT

Volume:265.23K

Turnover:1.12M

Market Cap:24.89M

PE:1.99

High:4.35

Open:3.83

Low:3.83

Close:3.70

Loading ...

Overview Company News Filings

X4 Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Chief Legal Officer Natasha Fay Thoren

Chief Commercial Officer Mark Baldry Acquires Common Shares of X4 Pharmaceuticals Inc

BRIEF-X4 Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Chronic Neutropenia Trial Data At The 30Th Annual Eha Congress

X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30TH Annual Eha Congress

THOMSON REUTERS

X4 Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

X4 Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

X4 Pharmaceuticals Inc (XFOR) Q1 2025 Earnings Call Highlights: Progress in Maverick 4 ...

BRIEF-X4 Pharmaceuticals Full Enrollment On Track For 3Q Or 4Q 2025 And Top-Line Data In 2H 2026

X4 Pharmaceuticals: Full Enrollment on Track for 3Q or 4Q 2025 and Top-Line Data in 2H 2026

THOMSON REUTERS

X4 Pharmaceuticals: Q1 Earnings Snapshot

Associated Press Finance

X4 Pharmaceuticals Q1 EPS $0.04 Beats $(4.44) Estimate, Sales $28.80M

X4 Pharmaceuticals Inc - Announces Strategic Restructuring to Focus on Mavorixafor

THOMSON REUTERS

X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

X4 Pharmaceuticals Inc expected to post a loss of $4.44 a share - Earnings Preview

BRIEF-X4 Pharmaceuticals Announces Reverse Stock Split

X4 Pharmaceuticals to Report First-Quarter 2025 Financial Results and Host Conference Call and Webcast on May 1, 2025

X4 Pharmaceuticals Announces Reverse Stock Split

THOMSON REUTERS

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), TriSalus Life Sciences (TLSI)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/XFOR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XFOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XFOR\",,,,,undefined,":{"symbol":"XFOR","market":"US","secType":"STK","nameCN":"X4 Pharmaceuticals Inc","latestPrice":4.3,"timestamp":1749240000000,"preClose":3.7,"halted":0,"volume":265231,"hourTrading":{"tag":"盘后","latestPrice":4.3,"preClose":4.3,"latestTime":"19:45 EDT","volume":165,"amount":705.86,"timestamp":1749253500089},"delay":0,"floatShares":4376292,"shares":5788686,"eps":2.164116,"marketStatus":"Market Closed","change":0.6,"latestTime":"06-06 16:00:00 EDT","open":3.83,"high":4.35,"low":3.83,"amount":1115781.0911756,"amplitude":0.140541,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":2.164116,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1510808400000,"exchange":"NASDAQ","adjPreClose":3.7,"preHourTrading":{"tag":"盘前","latestPrice":3.85,"preClose":3.7,"latestTime":"08:43 EDT","volume":425,"amount":1635.119925,"timestamp":1749213786503},"postHourTrading":{"tag":"盘后","latestPrice":4.3,"preClose":4.3,"latestTime":"19:45 EDT","volume":165,"amount":705.86,"timestamp":1749253500089},"volumeRatio":1.2065848541258377,"impliedVol":0.7201,"impliedVolPercentile":0.2568},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XFOR\",,,,,undefined,":{"symbol":"XFOR","floatShares":4376292,"roa":"-58.61%","roe":"121.75%","lyrEps":-5.587828,"volumeRatio":1.2065848541258377,"shares":5788686,"dividePrice":0,"high":4.35,"amplitude":0.140541,"preClose":3.7,"low":3.83,"week52Low":2.67,"pbRate":"1.08","psRate":"0.79","week52High":33.9,"institutionHeld":0,"latestPrice":4.3,"eps":2.164116,"divideRate":0,"volume":265231,"delay":0,"ttmEps":2.164116,"open":3.83,"prevYearClose":22.008,"prevWeekClose":3.4,"prevMonthClose":3.4,"prevQuarterClose":7.092,"fiveDayClose":3.4,"twentyDayClose":3.29,"sixtyDayClose":10.269},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XFOR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540700904","title":"X4 Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Chief Legal Officer Natasha Fay Thoren","url":"https://stock-news.laohu8.com/highlight/detail?id=2540700904","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540700904?lang=en_us&edition=fundamental","pubTime":"2025-06-04 06:13","pubTimestamp":1748988808,"startTime":"0","endTime":"0","summary":"X4 Pharmaceuticals Inc. filed an initial statement of beneficial ownership, listing Natasha Fay Thoren as the beneficial owner in her role as Chief Legal Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL54TBTb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2537259346","title":"Chief Commercial Officer Mark Baldry Acquires Common Shares of X4 Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537259346","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537259346?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:51","pubTimestamp":1747774302,"startTime":"0","endTime":"0","summary":"Mark Baldry, Chief Commercial Officer, reported an acquisition of common shares of X4 Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL5dGGKJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2535007973","title":"BRIEF-X4 Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Chronic Neutropenia Trial Data At The 30Th Annual Eha Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2535007973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535007973?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:16","pubTimestamp":1747253813,"startTime":"0","endTime":"0","summary":"BRIEF-X4 Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Chronic Neutropenia Trial Data At The 30Th Annual Eha CongressMay 14 (Reuters) - X4 Pharmaceuticals Inc XFOR.O:X4 PHARMACEUTICALS AN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA7DHVR3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2535700730","title":"X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30TH Annual Eha Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2535700730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535700730?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:12","pubTimestamp":1747253536,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA7DHVR3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2532829009","title":"X4 Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2532829009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532829009?lang=en_us&edition=fundamental","pubTime":"2025-05-03 00:08","pubTimestamp":1746202089,"startTime":"0","endTime":"0","summary":"X4 Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryX4 Pharmaceuticals Inc XFOR.OQ reported quarterly adjusted earnings of 4 cents per share for the quarter ended M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA2LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XFOR"],"gpt_icon":0},{"id":"2532846151","title":"X4 Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2532846151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532846151?lang=en_us&edition=fundamental","pubTime":"2025-05-02 20:57","pubTimestamp":1746190620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XFOR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 02, 2025 08:57 ET (12:57 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XFOR"],"gpt_icon":0},{"id":"2532916398","title":"X4 Pharmaceuticals Inc (XFOR) Q1 2025 Earnings Call Highlights: Progress in Maverick 4 ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2532916398","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532916398?lang=en_us&edition=fundamental","pubTime":"2025-05-02 15:06","pubTimestamp":1746169592,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.X4 Pharmaceuticals Inc  has made significant progress in the development of Maverick 4 for chronic neutropenia, with over 90% of global trial sites activated.The company has received a notice of allowance from the US Patent Office for Maverick 4, with the patent expected to expire in March 2041.X4 Pharmaceuticals Inc  reported cumulative sales of $3.5 million for Zoremby since its launch, indicating growing demand.The company has secured international partnerships to expand the reach of Maverick 4 in Europe, Australia, New Zealand, and the MENA region.X4 Pharmaceuticals Inc  had significant R&D and SG&A expenses, totaling $18.5 million and $15 million respectively for the first quarter.A:  Although the Phase 3 study includes moderate to severe patients, we aim for a broad label covering the entire CN population. We have supporting data from previous studies and anticipate discussions wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/x4-pharmaceuticals-inc-xfor-q1-070632643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRGS","XFOR"],"gpt_icon":0},{"id":"2532020699","title":"BRIEF-X4 Pharmaceuticals Full Enrollment On Track For 3Q Or 4Q 2025 And Top-Line Data In 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2532020699","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532020699?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:43","pubTimestamp":1746096205,"startTime":"0","endTime":"0","summary":"BRIEF-X4 Pharmaceuticals Full Enrollment On Track For 3Q Or 4Q 2025 And Top-Line Data In 2H 2026May 1  - X4 Pharmaceuticals Inc XFOR.O:X4 PHARMACEUTICALS: FULL ENROLLMENT ON TRACK FOR 3Q OR 4Q 2025 AND TOP-LINE DATA IN 2H 2026Source text: [ID:n0001628280-25-021304]Further company coverage: XFOR.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R838J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2532027524","title":"X4 Pharmaceuticals: Full Enrollment on Track for 3Q or 4Q 2025 and Top-Line Data in 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2532027524","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532027524?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:28","pubTimestamp":1746095313,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nFWN3R838J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2532020112","title":"X4 Pharmaceuticals: Q1 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2532020112","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532020112?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:11","pubTimestamp":1746094305,"startTime":"0","endTime":"0","summary":"BOSTON  — BOSTON  — X4 Pharmaceuticals, Inc.  on Thursday reported first-quarter earnings of $282,000.On a per-share basis, the Boston-based company said it had profit of 4 cents.The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $4.13 per share.The company posted revenue of $28.8 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $9 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/x4-pharmaceuticals-q1-earnings-snapshot-101145144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XFOR"],"gpt_icon":0},{"id":"2532902256","title":"X4 Pharmaceuticals Q1 EPS $0.04 Beats $(4.44) Estimate, Sales $28.80M","url":"https://stock-news.laohu8.com/highlight/detail?id=2532902256","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532902256?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:03","pubTimestamp":1746093803,"startTime":"0","endTime":"0","summary":"X4 Pharmaceuticals Q1 EPS $0.04 Beats $(4.44) Estimate, Sales $28.80M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45128272/x4-pharmaceuticals-q1-eps-0-04-beats-4-44-estimate-sales-28-80m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XFOR"],"gpt_icon":0},{"id":"2532022815","title":"X4 Pharmaceuticals Inc - Announces Strategic Restructuring to Focus on Mavorixafor","url":"https://stock-news.laohu8.com/highlight/detail?id=2532022815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532022815?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:01","pubTimestamp":1746093660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nTUA7DWQZT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2532102099","title":"X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2532102099","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532102099?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:01","pubTimestamp":1746093660,"startTime":"0","endTime":"0","summary":"4WARD Phase 3 chronic neutropenia trial in full swing; full enrollment on track for 3Q or 4Q 2025 and top-line data in 2H 2026. Additional analyses of mavorixafor clinical trial data increase confidence in successful outcome of 4WARD trial. XOLREMDI net U.S. revenues $3.5 million since May 2024 launch. As previously reported, an amendment to the 4WARD protocol has been implemented, focusing enrollment on those with the highest unmet needs and refining the definition of ANC response, making it consistent across all trial participants. Overall, the trial seeks to demonstrate statistically significant increases in ANC response and corresponding decreases in annualized infection rate between those on mavorixafor versus placebo.To date, the demographics of the enrolled population are balanced and representative of the targeted commercial CN patient populations; baseline absolute neutrophil counts  and historical infection rates are consistent with this high unmet need population.Further Dat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/x4-pharmaceuticals-reports-first-quarter-100100798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XFOR","BK4588","MAA","BK4585","BK4215","CN","BK4139"],"gpt_icon":0},{"id":"2531073416","title":"X4 Pharmaceuticals Inc  expected to post a loss of $4.44 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2531073416","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531073416?lang=en_us&edition=fundamental","pubTime":"2025-04-29 21:16","pubTimestamp":1745932574,"startTime":"0","endTime":"0","summary":"X4 Pharmaceuticals Inc  expected to post a loss of $4.44 a share - Earnings Preview X4 Pharmaceuticals Inc XFOR.OQ XFOR.O is expected to show a rise in quarterly revenue when it reports  results on Ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL8N3R71RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XFOR"],"gpt_icon":0},{"id":"2529981673","title":"BRIEF-X4 Pharmaceuticals Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2529981673","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529981673?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:26","pubTimestamp":1745497562,"startTime":"0","endTime":"0","summary":"BRIEF-X4 Pharmaceuticals Announces Reverse Stock SplitApril 24 (Reuters) - X4 Pharmaceuticals Inc XFOR.O:X4 PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLITX4 PHARMACEUTICALS INC - ANNOUNCES ONE-FOR-THIR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA1TJXYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2529393351","title":"X4 Pharmaceuticals to Report First-Quarter 2025 Financial Results and Host  Conference Call and Webcast on May 1, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529393351","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529393351?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:03","pubTimestamp":1745496180,"startTime":"0","endTime":"0","summary":"BOSTON, April 24, 2025  -- X4 Pharmaceuticals , a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will report financial results for the first quarter ended March 31, 2025 and provide corporate updates on Thursday, May 1, 2025.About X4 PharmaceuticalsX4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging expertise in CXCR4 and immune system biology, X4 has successfully developed mavorixafor, an orally available CXCR4 antagonist that is currently being marketed in the U.S. as XOLREMDI in its first indication. The company is also evaluating additional uses of mavorixafor and is conducting a global, pivotal Phase 3 clinical trial  in people with certain chronic neutropenic disorders. X4 is headquartered in Boston, Massachusetts. For more information, please visit www.x4pharma.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/x4-pharmaceuticals-report-first-quarter-120300747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XFOR","BK4139","BK4218","HST","BK4588","BK4585","BK4181"],"gpt_icon":0},{"id":"2529663985","title":"X4 Pharmaceuticals Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663985","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663985?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA1TJXYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2529650593","title":"X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529650593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529650593?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:05","pubTimestamp":1745438701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nTUA5QYFNJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2529663728","title":"X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663728","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663728?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:05","pubTimestamp":1745438700,"startTime":"0","endTime":"0","summary":"BOSTON, April 23, 2025  -- X4 Pharmaceuticals , a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan . The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 450,471 shares of X4’s common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635 and were approved by X4’s Compensation Committee of the Board of Directors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/x4-pharmaceuticals-announces-inducement-grants-200500347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","LU2095319765.USD","IE00BKPKM429.USD","QID","NVIW.SI","QLD","IE00BGHQF748.EUR","NDAQ","SQQQ","TQQQ","USJW.SI","XFOR",".IXIC","PSQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","USAW.SI","BK4139","BK4112","BK4588","TSYW.SI","BK4585","LU2210149790.SGD","NQmain","LU2210150020.SGD"],"gpt_icon":1},{"id":"2522535353","title":"Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), TriSalus Life Sciences (TLSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522535353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522535353?lang=en_us&edition=fundamental","pubTime":"2025-03-28 02:50","pubTimestamp":1743101415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on X4 Pharmaceuticals (XFOR – Research Report) and TriS...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-x4-pharmaceuticals-xfor-trisalus-life-sciences-tlsi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-x4-pharmaceuticals-xfor-trisalus-life-sciences-tlsi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XFOR","TLSI","HCSG","BK4139","BK4137"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XFOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-01","symbol":"XFOR","fiscalQuarterEnding":"2025/03","expectedEps":-4.13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":0.04},{"market":"US","date":"2025-04-28","symbol":"XFOR","defaultRemindTime":1745847000000,"type":"split","dateTimestamp":1745812800000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-03-25","symbol":"XFOR","fiscalQuarterEnding":"2024/12","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-13","symbol":"XFOR","fiscalQuarterEnding":"2024/09","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-08-08","symbol":"XFOR","fiscalQuarterEnding":"2024/06","expectedEps":-0.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XFOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XFOR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1702440000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XFOR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XFOR","date":"2025-06-05","current":1.60202,"percent":0.945172,"low":-8.223558,"twenty":-2.525254,"median":-1.461264,"eighty":-0.774503,"high":7.404346,"avg":-1.396061,"sd":2.189605,"marketCap":23386291},"quantilePoints":[{"date":"2020-06-12","current":-2.591426,"twenty":-4.861493,"median":-3.331354,"eighty":-2.803155,"marketCap":137532183},{"date":"2020-06-19","current":-2.995957,"twenty":-4.835071,"median":-3.32629,"eighty":-2.803155,"marketCap":159001408},{"date":"2020-06-26","current":-2.627925,"twenty":-4.780468,"median":-3.32629,"eighty":-2.803155,"marketCap":139469256},{"date":"2020-07-02","current":-2.728298,"twenty":-4.777767,"median":-3.319499,"eighty":-2.777054,"marketCap":144796206},{"date":"2020-07-10","current":-2.469763,"twenty":-4.766289,"median":-3.311779,"eighty":-2.767838,"marketCap":131075273},{"date":"2020-07-17","current":-2.497137,"twenty":-4.725626,"median":-3.31117,"eighty":-2.751159,"marketCap":132528077},{"date":"2020-07-24","current":-2.433264,"twenty":-4.714194,"median":-3.306146,"eighty":-2.739856,"marketCap":129138200},{"date":"2020-07-31","current":-2.184372,"twenty":-4.710399,"median":-3.285467,"eighty":-2.72769,"marketCap":119775680},{"date":"2020-08-07","current":-2.463314,"twenty":-4.682563,"median":-3.280801,"eighty":-2.703965,"marketCap":135070885},{"date":"2020-08-14","current":-2.610818,"twenty":-4.665008,"median":-3.268836,"eighty":-2.696823,"marketCap":143158962},{"date":"2020-08-21","current":-2.457414,"twenty":-4.640701,"median":-3.262788,"eighty":-2.689522,"marketCap":134747362},{"date":"2020-08-28","current":-2.433813,"twenty":-4.633948,"median":-3.241621,"eighty":-2.673465,"marketCap":133453270},{"date":"2020-09-04","current":-2.436763,"twenty":-4.624158,"median":-3.229525,"eighty":-2.666755,"marketCap":133615032},{"date":"2020-09-11","current":-2.31876,"twenty":-4.585334,"median":-3.226501,"eighty":-2.648017,"marketCap":127144570},{"date":"2020-09-18","current":-2.203707,"twenty":-4.514283,"median":-3.214406,"eighty":-2.635225,"marketCap":120835870},{"date":"2020-09-25","current":-1.796597,"twenty":-4.438711,"median":-3.190214,"eighty":-2.612567,"marketCap":98512777},{"date":"2020-10-02","current":-1.964751,"twenty":-4.401002,"median":-3.17616,"eighty":-2.599336,"marketCap":107733185},{"date":"2020-10-09","current":-2.183057,"twenty":-4.391549,"median":-3.166023,"eighty":-2.588562,"marketCap":119703539},{"date":"2020-10-16","current":-1.998963,"twenty":-4.369589,"median":-3.159739,"eighty":-2.564964,"marketCap":109609120},{"date":"2020-10-23","current":-1.921737,"twenty":-4.351702,"median":-3.144856,"eighty":-2.537052,"marketCap":105374593},{"date":"2020-10-30","current":-1.70491,"twenty":-4.318453,"median":-3.139313,"eighty":-2.519037,"marketCap":93485342},{"date":"2020-11-06","current":-1.650512,"twenty":-4.253937,"median":-3.120665,"eighty":-2.510244,"marketCap":90065146},{"date":"2020-11-13","current":-1.922115,"twenty":-4.223736,"median":-3.105965,"eighty":-2.493688,"marketCap":104885993},{"date":"2020-11-20","current":-1.948977,"twenty":-4.223367,"median":-3.090011,"eighty":-2.479314,"marketCap":106351791},{"date":"2020-11-27","current":-2.029563,"twenty":-4.209037,"median":-3.087402,"eighty":-2.469763,"marketCap":110749186},{"date":"2020-12-04","current":-2.065379,"twenty":-4.179712,"median":-3.070963,"eighty":-2.4595,"marketCap":112703583},{"date":"2020-12-11","current":-1.793775,"twenty":-4.163379,"median":-3.04926,"eighty":-2.436763,"marketCap":97882736},{"date":"2020-12-18","current":-1.9251,"twenty":-4.117171,"median":-3.037183,"eighty":-2.429614,"marketCap":105048860},{"date":"2020-12-24","current":-2.092241,"twenty":-4.057322,"median":-3.024358,"eighty":-2.409778,"marketCap":114169381},{"date":"2020-12-31","current":-1.919131,"twenty":-4.054621,"median":-3.021527,"eighty":-2.374812,"marketCap":104723127},{"date":"2021-01-08","current":-2.468307,"twenty":-4.017484,"median":-3.017105,"eighty":-2.365961,"marketCap":134690554},{"date":"2021-01-15","current":-2.536954,"twenty":-3.9961,"median":-3.004245,"eighty":-2.360061,"marketCap":138436482},{"date":"2021-01-22","current":-2.533969,"twenty":-3.962306,"median":-3.002733,"eighty":-2.364781,"marketCap":138273616},{"date":"2021-01-29","current":-2.331013,"twenty":-3.944846,"median":-2.989593,"eighty":-2.354154,"marketCap":127198697},{"date":"2021-02-05","current":-2.504122,"twenty":-3.915559,"median":-2.977708,"eighty":-2.350621,"marketCap":136644951},{"date":"2021-02-12","current":-2.647386,"twenty":-3.902041,"median":-2.956416,"eighty":-2.354154,"marketCap":144462541},{"date":"2021-02-19","current":-2.877204,"twenty":-3.876695,"median":-2.945279,"eighty":-2.357993,"marketCap":157003257},{"date":"2021-02-26","current":-2.856311,"twenty":-3.840649,"median":-2.903302,"eighty":-2.363601,"marketCap":155863192},{"date":"2021-03-05","current":-2.490273,"twenty":-3.819806,"median":-2.904002,"eighty":-2.367731,"marketCap":154723127},{"date":"2021-03-12","current":-2.503379,"twenty":-3.810871,"median":-2.895198,"eighty":-2.371243,"marketCap":155537459},{"date":"2021-03-19","current":-2.770056,"twenty":-3.795892,"median":-2.883418,"eighty":-2.367731,"marketCap":172106332},{"date":"2021-03-26","current":-2.560203,"twenty":-3.765549,"median":-2.876792,"eighty":-2.370952,"marketCap":159067973},{"date":"2021-04-01","current":-2.526627,"twenty":-3.744025,"median":-2.874256,"eighty":-2.370887,"marketCap":156981836},{"date":"2021-04-09","current":-2.523829,"twenty":-3.719374,"median":-2.859085,"eighty":-2.372506,"marketCap":156807991},{"date":"2021-04-16","current":-2.521031,"twenty":-3.693083,"median":-2.851116,"eighty":-2.372506,"marketCap":156634146},{"date":"2021-04-23","current":-3.283353,"twenty":-3.682945,"median":-2.856311,"eighty":-2.373604,"marketCap":203997989},{"date":"2021-04-30","current":-3.191937,"twenty":-3.671118,"median":-2.870769,"eighty":-2.374812,"marketCap":198318230},{"date":"2021-05-07","current":-2.733326,"twenty":-3.659854,"median":-2.874219,"eighty":-2.37622,"marketCap":190428063},{"date":"2021-05-14","current":-2.590717,"twenty":-3.650279,"median":-2.857698,"eighty":-2.380893,"marketCap":180492685},{"date":"2021-05-21","current":-2.682394,"twenty":-3.638451,"median":-2.845922,"eighty":-2.385486,"marketCap":186879714},{"date":"2021-05-28","current":-3.225664,"twenty":-3.638451,"median":-2.856311,"eighty":-2.392512,"marketCap":224728770},{"date":"2021-06-04","current":-3.035519,"twenty":-3.637102,"median":-2.863202,"eighty":-2.402368,"marketCap":211481600},{"date":"2021-06-11","current":-2.967611,"twenty":-3.630237,"median":-2.874293,"eighty":-2.406898,"marketCap":206750468},{"date":"2021-06-18","current":-2.519413,"twenty":-3.621835,"median":-2.863202,"eighty":-2.408967,"marketCap":175524997},{"date":"2021-06-25","current":-2.488428,"twenty":-3.611415,"median":-2.856311,"eighty":-2.408967,"marketCap":173366305},{"date":"2021-07-02","current":-2.200482,"twenty":-3.606346,"median":-2.847346,"eighty":-2.385111,"marketCap":153305346},{"date":"2021-07-09","current":-2.25025,"twenty":-3.590576,"median":-2.839949,"eighty":-2.374812,"marketCap":156772672},{"date":"2021-07-16","current":-1.987188,"twenty":-3.579312,"median":-2.819545,"eighty":-2.368911,"marketCap":138445377},{"date":"2021-07-23","current":-2.044066,"twenty":-3.577525,"median":-2.801379,"eighty":-2.360452,"marketCap":142408036},{"date":"2021-07-30","current":-2.044066,"twenty":-3.565178,"median":-2.777332,"eighty":-2.351211,"marketCap":142408036},{"date":"2021-08-06","current":-2.044079,"twenty":-3.539886,"median":-2.771981,"eighty":-2.31876,"marketCap":151595052},{"date":"2021-08-13","current":-1.896638,"twenty":-3.531437,"median":-2.770056,"eighty":-2.30991,"marketCap":140660327},{"date":"2021-08-20","current":-1.595052,"twenty":-3.531437,"median":-2.762466,"eighty":-2.289354,"marketCap":118293844},{"date":"2021-08-27","current":-1.65872,"twenty":-3.522989,"median":-2.754773,"eighty":-2.275633,"marketCap":123015657},{"date":"2021-09-03","current":-1.739143,"twenty":-3.520173,"median":-2.751159,"eighty":-2.218256,"marketCap":128980053},{"date":"2021-09-10","current":-1.645316,"twenty":-3.513414,"median":-2.750303,"eighty":-2.184109,"marketCap":122021591},{"date":"2021-09-17","current":-1.769301,"twenty":-3.509471,"median":-2.748725,"eighty":-2.1622,"marketCap":131216701},{"date":"2021-09-24","current":-1.856426,"twenty":-3.508908,"median":-2.738666,"eighty":-2.140048,"marketCap":137678129},{"date":"2021-10-01","current":-1.725739,"twenty":-3.50215,"median":-2.733326,"eighty":-2.120628,"marketCap":127985987},{"date":"2021-10-08","current":-1.772652,"twenty":-3.50046,"median":-2.728298,"eighty":-2.102644,"marketCap":131465217},{"date":"2021-10-15","current":-1.752547,"twenty":-3.495954,"median":-2.719744,"eighty":-2.085197,"marketCap":129974119},{"date":"2021-10-22","current":-1.511278,"twenty":-3.493149,"median":-2.707711,"eighty":-2.064134,"marketCap":112080932},{"date":"2021-10-29","current":-1.62186,"twenty":-3.485396,"median":-2.703965,"eighty":-2.044405,"marketCap":120281976},{"date":"2021-11-05","current":-1.60031,"twenty":-3.48131,"median":-2.698601,"eighty":-2.043553,"marketCap":123046203},{"date":"2021-11-12","current":-1.577815,"twenty":-3.478494,"median":-2.69484,"eighty":-2.03323,"marketCap":121316638},{"date":"2021-11-19","current":-1.53604,"twenty":-3.477675,"median":-2.688772,"eighty":-2.01464,"marketCap":118104588},{"date":"2021-11-26","current":-1.45249,"twenty":-3.471044,"median":-2.684495,"eighty":-2.013181,"marketCap":111680489},{"date":"2021-12-03","current":-1.143996,"twenty":-3.465345,"median":-2.679632,"eighty":-2.002068,"marketCap":87960739},{"date":"2021-12-10","current":-1.23076,"twenty":-3.464096,"median":-2.676077,"eighty":-1.996022,"marketCap":94631919},{"date":"2021-12-17","current":-0.793728,"twenty":-3.46068,"median":-2.673128,"eighty":-1.978824,"marketCap":61028940},{"date":"2021-12-23","current":-0.903568,"twenty":-3.4573,"median":-2.667466,"eighty":-1.96987,"marketCap":69474468},{"date":"2021-12-31","current":-0.837721,"twenty":-3.455402,"median":-2.661874,"eighty":-1.965194,"marketCap":64411551},{"date":"2022-01-07","current":-0.808456,"twenty":-3.454275,"median":-2.649216,"eighty":-1.955329,"marketCap":62161366},{"date":"2022-01-14","current":-0.764567,"twenty":-3.451459,"median":-2.646197,"eighty":-1.947353,"marketCap":58786803},{"date":"2022-01-21","current":-0.669454,"twenty":-3.449206,"median":-2.643638,"eighty":-1.923776,"marketCap":51473612},{"date":"2022-01-28","current":-0.71701,"twenty":-3.446953,"median":-2.630154,"eighty":-1.919131,"marketCap":55130207},{"date":"2022-02-04","current":-0.67677,"twenty":-3.445263,"median":-2.61969,"eighty":-1.911884,"marketCap":52036165},{"date":"2022-02-11","current":-0.570682,"twenty":-3.438505,"median":-2.612717,"eighty":-1.896638,"marketCap":43879144},{"date":"2022-02-18","current":-0.570682,"twenty":-3.436423,"median":-2.607895,"eighty":-1.87002,"marketCap":43879144},{"date":"2022-02-25","current":-0.567023,"twenty":-3.428095,"median":-2.602883,"eighty":-1.856426,"marketCap":43597868},{"date":"2022-03-04","current":-0.731643,"twenty":-3.424424,"median":-2.59751,"eighty":-1.842388,"marketCap":56255314},{"date":"2022-03-11","current":-0.768225,"twenty":-3.424286,"median":-2.592966,"eighty":-1.820637,"marketCap":59068079},{"date":"2022-03-18","current":-0.583564,"twenty":-3.415976,"median":-2.584641,"eighty":-1.79676,"marketCap":51759751},{"date":"2022-03-25","current":-0.705139,"twenty":-3.407527,"median":-2.577878,"eighty":-1.779354,"marketCap":62543033},{"date":"2022-04-01","current":-0.656509,"twenty":-3.393447,"median":-2.563001,"eighty":-1.772652,"marketCap":58229720},{"date":"2022-04-08","current":-0.607879,"twenty":-3.387814,"median":-2.557565,"eighty":-1.769301,"marketCap":53916408},{"date":"2022-04-14","current":-0.49325,"twenty":-3.386144,"median":-2.552627,"eighty":-1.757909,"marketCap":43749313},{"date":"2022-04-22","current":-0.451775,"twenty":-3.382891,"median":-2.545803,"eighty":-1.741824,"marketCap":40070644},{"date":"2022-04-29","current":-0.4483,"twenty":-3.379929,"median":-2.537368,"eighty":-1.732281,"marketCap":39762409},{"date":"2022-05-06","current":-0.389222,"twenty":-3.35747,"median":-2.533969,"eighty":-1.718367,"marketCap":34522401},{"date":"2022-05-13","current":-0.402112,"twenty":-3.351362,"median":-2.530506,"eighty":-1.703714,"marketCap":36988287},{"date":"2022-05-20","current":-0.388708,"twenty":-3.335434,"median":-2.526627,"eighty":-1.675475,"marketCap":35755344},{"date":"2022-05-27","current":-0.418867,"twenty":-3.331271,"median":-2.522649,"eighty":-1.667292,"marketCap":38529466},{"date":"2022-06-03","current":-0.408814,"twenty":-3.330075,"median":-2.520222,"eighty":-1.65738,"marketCap":37604759},{"date":"2022-06-10","current":-0.412165,"twenty":-3.3275,"median":-2.512636,"eighty":-1.648667,"marketCap":37912994},{"date":"2022-06-17","current":-0.361901,"twenty":-3.32629,"median":-2.512345,"eighty":-1.62052,"marketCap":33289458},{"date":"2022-06-24","current":-0.35855,"twenty":-3.32629,"median":-2.510176,"eighty":-1.608456,"marketCap":32981223},{"date":"2022-07-01","current":-0.348497,"twenty":-3.32629,"median":-2.504242,"eighty":-1.597155,"marketCap":32056515},{"date":"2022-07-08","current":-0.375305,"twenty":-3.325349,"median":-2.503379,"eighty":-1.55826,"marketCap":34522401},{"date":"2022-07-15","current":-0.35855,"twenty":-3.320752,"median":-2.496688,"eighty":-1.537325,"marketCap":32981223},{"date":"2022-07-22","current":-0.885823,"twenty":-3.317372,"median":-2.492184,"eighty":-1.512618,"marketCap":81482464},{"date":"2022-07-29","current":-0.955231,"twenty":-3.31613,"median":-2.489146,"eighty":-1.456205,"marketCap":87866967},{"date":"2022-08-05","current":-0.880463,"twenty":-3.311657,"median":-2.484016,"eighty":-1.431281,"marketCap":82375281},{"date":"2022-08-12","current":-1.041882,"twenty":-3.31117,"median":-2.48111,"eighty":-1.235902,"marketCap":97477416},{"date":"2022-08-19","current":-0.766737,"twenty":-3.31117,"median":-2.475273,"eighty":-1.118289,"marketCap":71735141},{"date":"2022-08-26","current":-0.770406,"twenty":-3.310728,"median":-2.470963,"eighty":-0.984502,"marketCap":72078371},{"date":"2022-09-02","current":-0.755731,"twenty":-3.308399,"median":-2.469763,"eighty":-0.948245,"marketCap":70705450},{"date":"2022-09-09","current":-0.865789,"twenty":-3.306146,"median":-2.463314,"eighty":-0.931824,"marketCap":81002360},{"date":"2022-09-16","current":-0.807092,"twenty":-3.302099,"median":-2.459426,"eighty":-0.885823,"marketCap":75510674},{"date":"2022-09-23","current":-0.675169,"twenty":-3.29478,"median":-2.445431,"eighty":-0.878379,"marketCap":63168111},{"date":"2022-09-30","current":-1.25466,"twenty":-3.286979,"median":-2.439887,"eighty":-0.878379,"marketCap":117384776},{"date":"2022-10-07","current":-1.614183,"twenty":-3.283955,"median":-2.436763,"eighty":-0.878379,"marketCap":151021349},{"date":"2022-10-14","current":-1.482114,"twenty":-3.283955,"median":-2.434052,"eighty":-0.880463,"marketCap":138665057},{"date":"2022-10-21","current":-1.467439,"twenty":-3.283353,"median":-2.432491,"eighty":-0.880463,"marketCap":137292136},{"date":"2022-10-28","current":-1.430753,"twenty":-3.280801,"median":-2.419042,"eighty":-0.885823,"marketCap":133859832},{"date":"2022-11-04","current":-1.348688,"twenty":-3.272465,"median":-2.409109,"eighty":-0.893267,"marketCap":128084886},{"date":"2022-11-11","current":-1.450751,"twenty":-3.268836,"median":-2.403876,"eighty":-0.903568,"marketCap":137777797},{"date":"2022-11-18","current":-1.370558,"twenty":-3.268836,"median":-2.384736,"eighty":-0.917149,"marketCap":130161939},{"date":"2022-11-25","current":-1.312237,"twenty":-3.26489,"median":-2.374812,"eighty":-0.927819,"marketCap":124623133},{"date":"2022-12-02","current":-1.006048,"twenty":-3.263011,"median":-2.372555,"eighty":-0.931557,"marketCap":95544402},{"date":"2022-12-09","current":-1.19014,"twenty":-3.25467,"median":-2.368911,"eighty":-0.914433,"marketCap":113027618},{"date":"2022-12-16","current":-1.002917,"twenty":-3.248663,"median":-2.36629,"eighty":-0.927819,"marketCap":95247037},{"date":"2022-12-23","current":-1.102351,"twenty":-3.245744,"median":-2.360061,"eighty":-0.927819,"marketCap":104690312},{"date":"2022-12-30","current":-1.270763,"twenty":-3.239449,"median":-2.35489,"eighty":-0.931289,"marketCap":120684328},{"date":"2023-01-06","current":-1.497273,"twenty":-3.235573,"median":-2.348261,"eighty":-0.934759,"marketCap":142196036},{"date":"2023-01-13","current":-1.548462,"twenty":-3.233355,"median":-2.324886,"eighty":-0.939671,"marketCap":147057439},{"date":"2023-01-20","current":-1.394896,"twenty":-3.229927,"median":-2.312294,"eighty":-0.94111,"marketCap":132473230},{"date":"2023-01-27","current":-1.343707,"twenty":-3.229525,"median":-2.30991,"eighty":-0.944346,"marketCap":127611827},{"date":"2023-02-03","current":-1.33091,"twenty":-3.22892,"median":-2.29853,"eighty":-0.948245,"marketCap":126396476},{"date":"2023-02-10","current":-1.241329,"twenty":-3.226334,"median":-2.280565,"eighty":-0.956724,"marketCap":117889021},{"date":"2023-02-17","current":-1.253998,"twenty":-3.225664,"median":-2.277953,"eighty":-0.963696,"marketCap":119092219},{"date":"2023-02-24","current":-1.178751,"twenty":-3.225664,"median":-2.241863,"eighty":-0.967706,"marketCap":111945956},{"date":"2023-03-03","current":-1.228532,"twenty":-3.225664,"median":-2.218256,"eighty":-0.970157,"marketCap":116673671},{"date":"2023-03-10","current":-1.132809,"twenty":-3.225664,"median":-2.192427,"eighty":-0.985257,"marketCap":107582847},{"date":"2023-03-17","current":-1.074965,"twenty":-3.214406,"median":-2.183057,"eighty":-0.987432,"marketCap":102089462},{"date":"2023-03-24","current":-1.087467,"twenty":-3.214406,"median":-2.161892,"eighty":-1.002917,"marketCap":102077308},{"date":"2023-03-31","current":-1.12644,"twenty":-3.214406,"median":-2.150606,"eighty":-1.006048,"marketCap":105735514},{"date":"2023-04-06","current":-1.078145,"twenty":-3.205572,"median":-2.140048,"eighty":-1.016238,"marketCap":101202256},{"date":"2023-04-14","current":-1.579605,"twenty":-3.202483,"median":-2.124055,"eighty":-1.025114,"marketCap":148272790},{"date":"2023-04-21","current":-1.760871,"twenty":-3.200538,"median":-2.118719,"eighty":-1.030694,"marketCap":165287700},{"date":"2023-04-28","current":-1.978921,"twenty":-3.198355,"median":-2.108054,"eighty":-1.034424,"marketCap":185755381},{"date":"2023-05-05","current":-2.004959,"twenty":-3.197774,"median":-2.095225,"eighty":-1.041181,"marketCap":188199531},{"date":"2023-05-12","current":-1.898304,"twenty":-3.191937,"median":-2.093398,"eighty":-1.041882,"marketCap":182089157},{"date":"2023-05-19","current":-2.471618,"twenty":-3.190214,"median":-2.094554,"eighty":-1.049219,"marketCap":237082526},{"date":"2023-05-26","current":-2.5608,"twenty":-3.184319,"median":-2.106276,"eighty":-1.049789,"marketCap":245637050},{"date":"2023-06-02","current":-2.828346,"twenty":-3.184197,"median":-2.118246,"eighty":-1.061072,"marketCap":271300623},{"date":"2023-06-09","current":-2.739164,"twenty":-3.178081,"median":-2.124055,"eighty":-1.067008,"marketCap":262746099},{"date":"2023-06-16","current":-3.755287,"twenty":-3.193104,"median":-2.140048,"eighty":-1.070542,"marketCap":360214654},{"date":"2023-06-23","current":-3.275537,"twenty":-3.202483,"median":-2.15498,"eighty":-1.072858,"marketCap":314196042},{"date":"2023-06-30","current":-3.060476,"twenty":-3.202777,"median":-2.161892,"eighty":-1.074225,"marketCap":293567009},{"date":"2023-07-07","current":-3.060476,"twenty":-3.201217,"median":-2.172502,"eighty":-1.074649,"marketCap":293567009},{"date":"2023-07-14","current":-3.126649,"twenty":-3.201217,"median":-2.183057,"eighty":-1.074712,"marketCap":299914404},{"date":"2023-07-21","current":-3.093563,"twenty":-3.198355,"median":-2.202095,"eighty":-1.075601,"marketCap":296740706},{"date":"2023-07-28","current":-2.81233,"twenty":-3.196783,"median":-2.223565,"eighty":-1.0782,"marketCap":269764279},{"date":"2023-08-04","current":-2.944675,"twenty":-3.192644,"median":-2.246271,"eighty":-1.079726,"marketCap":282459068},{"date":"2023-08-11","current":-1.277538,"twenty":-3.191592,"median":-2.25025,"eighty":-1.085451,"marketCap":166619113},{"date":"2023-08-18","current":-1.50025,"twenty":-3.189035,"median":-2.228521,"eighty":-1.087493,"marketCap":195665627},{"date":"2023-08-25","current":-1.5885,"twenty":-3.184289,"median":-2.203707,"eighty":-1.088726,"marketCap":207175370},{"date":"2023-09-01","current":-1.613714,"twenty":-3.182646,"median":-2.183714,"eighty":-1.0933,"marketCap":210463868},{"date":"2023-09-08","current":-1.594804,"twenty":-3.17656,"median":-2.181105,"eighty":-1.093531,"marketCap":207997494},{"date":"2023-09-15","current":-1.525464,"twenty":-3.176278,"median":-2.162406,"eighty":-1.102351,"marketCap":198954125},{"date":"2023-09-22","current":-1.32375,"twenty":-3.176278,"median":-2.15498,"eighty":-1.107018,"marketCap":172646141},{"date":"2023-09-28","current":-1.386786,"twenty":-3.175864,"median":-2.140048,"eighty":-1.107737,"marketCap":180867386},{"date":"2023-10-06","current":-1.18898,"twenty":-3.17569,"median":-2.132052,"eighty":-1.108706,"marketCap":155069120},{"date":"2023-10-13","current":-1.111068,"twenty":-3.173533,"median":-2.121105,"eighty":-1.111227,"marketCap":144907661},{"date":"2023-10-20","current":-1.046393,"twenty":-3.1679,"median":-2.118246,"eighty":-1.107737,"marketCap":136472664},{"date":"2023-10-27","current":-0.956882,"twenty":-3.165418,"median":-2.112913,"eighty":-1.103284,"marketCap":124798496},{"date":"2023-11-03","current":-1.008572,"twenty":-3.162904,"median":-2.095225,"eighty":-1.087493,"marketCap":131539917},{"date":"2023-11-10","current":-1.189121,"twenty":-3.16141,"median":-2.088972,"eighty":-1.085451,"marketCap":132160055},{"date":"2023-11-17","current":-1.152544,"twenty":-3.156347,"median":-2.082754,"eighty":-1.087493,"marketCap":128094878},{"date":"2023-11-24","current":-1.205076,"twenty":-3.153928,"median":-2.068004,"eighty":-1.087597,"marketCap":133933341},{"date":"2023-12-01","current":-1.174068,"twenty":-3.144856,"median":-2.058719,"eighty":-1.093242,"marketCap":130487143},{"date":"2023-12-08","current":-1.356952,"twenty":-3.143812,"median":-2.050303,"eighty":-1.093531,"marketCap":150813024},{"date":"2023-12-15","current":-1.072918,"twenty":-3.143192,"median":-2.044079,"eighty":-1.087467,"marketCap":119245173},{"date":"2023-12-22","current":-1.119279,"twenty":-3.141832,"median":-2.044066,"eighty":-1.084947,"marketCap":124397743},{"date":"2023-12-29","current":-1.300808,"twenty":-3.1412,"median":-2.042759,"eighty":-1.086459,"marketCap":144573062},{"date":"2024-01-05","current":-1.254598,"twenty":-3.139981,"median":-2.040546,"eighty":-1.087493,"marketCap":139437222},{"date":"2024-01-12","current":-1.264532,"twenty":-3.135554,"median":-2.032974,"eighty":-1.087852,"marketCap":140541344},{"date":"2024-01-19","current":-1.151942,"twenty":-3.130592,"median":-2.025086,"eighty":-1.088873,"marketCap":128027962},{"date":"2024-01-26","current":-1.11115,"twenty":-3.126649,"median":-2.01464,"eighty":-1.088873,"marketCap":123494370},{"date":"2024-02-02","current":-1.264532,"twenty":-3.123689,"median":-2.012996,"eighty":-1.093242,"marketCap":140541344},{"date":"2024-02-09","current":-1.300958,"twenty":-3.120665,"median":-2.005686,"eighty":-1.093531,"marketCap":144589791},{"date":"2024-02-16","current":-1.423934,"twenty":-3.120665,"median":-2.00181,"eighty":-1.095515,"marketCap":158257483},{"date":"2024-02-23","current":-1.364629,"twenty":-3.112218,"median":-1.998407,"eighty":-1.096825,"marketCap":151666210},{"date":"2024-03-01","current":-1.460963,"twenty":-3.110106,"median":-1.995393,"eighty":-1.098597,"marketCap":162372847},{"date":"2024-03-08","current":-1.379831,"twenty":-3.110106,"median":-1.988975,"eighty":-1.101672,"marketCap":153355851},{"date":"2024-03-15","current":-1.26122,"twenty":-3.105881,"median":-1.978824,"eighty":-1.105151,"marketCap":140173304},{"date":"2024-03-22","current":-2.166235,"twenty":-3.088608,"median":-1.96987,"eighty":-1.105151,"marketCap":219151483},{"date":"2024-03-28","current":-2.340608,"twenty":-3.075991,"median":-1.96987,"eighty":-1.105151,"marketCap":236792271},{"date":"2024-04-05","current":-2.440208,"twenty":-3.048983,"median":-1.96987,"eighty":-1.104218,"marketCap":246868538},{"date":"2024-04-12","current":-2.050107,"twenty":-3.025898,"median":-1.96987,"eighty":-1.104218,"marketCap":207403159},{"date":"2024-04-19","current":-1.992007,"twenty":-3.021866,"median":-1.96987,"eighty":-1.104218,"marketCap":201525337},{"date":"2024-04-26","current":-1.875806,"twenty":-3.012439,"median":-1.968377,"eighty":-1.105151,"marketCap":189769692},{"date":"2024-05-03","current":-1.792806,"twenty":-3.002733,"median":-1.958103,"eighty":-1.105151,"marketCap":181372803},{"date":"2024-05-10","current":-1.387399,"twenty":-2.987292,"median":-1.948977,"eighty":-1.105151,"marketCap":178853736},{"date":"2024-05-17","current":-1.250222,"twenty":-2.965098,"median":-1.932487,"eighty":-1.105151,"marketCap":161169888},{"date":"2024-05-24","current":-1.17258,"twenty":-2.958337,"median":-1.920434,"eighty":-1.105151,"marketCap":151160796},{"date":"2024-05-31","current":-1.271326,"twenty":-2.944917,"median":-1.913493,"eighty":-1.105151,"marketCap":163890480},{"date":"2024-06-07","current":-1.328776,"twenty":-2.906214,"median":-1.900945,"eighty":-1.105151,"marketCap":171296536},{"date":"2024-06-14","current":-1.380885,"twenty":-2.889996,"median":-1.893287,"eighty":-1.104218,"marketCap":178014047},{"date":"2024-06-21","current":-1.250613,"twenty":-2.878242,"median":-1.875287,"eighty":-1.103284,"marketCap":161220269},{"date":"2024-06-28","current":-0.872954,"twenty":-2.870079,"median":-1.866479,"eighty":-1.098236,"marketCap":112535107},{"date":"2024-07-05","current":-0.735386,"twenty":-2.856311,"median":-1.851504,"eighty":-1.091494,"marketCap":94800877},{"date":"2024-07-12","current":-0.900702,"twenty":-2.83964,"median":-1.839671,"eighty":-1.081621,"marketCap":116112181},{"date":"2024-07-15","current":-0.914641,"twenty":-2.836213,"median":-1.834306,"eighty":-1.078311,"marketCap":117909116},{"date":"2024-08-02","current":-1.010912,"twenty":-2.790125,"median":-1.79811,"eighty":-1.074649,"marketCap":130319718},{"date":"2024-08-09","current":6.205278,"twenty":-2.772741,"median":-1.78608,"eighty":-1.071231,"marketCap":109411464},{"date":"2024-08-16","current":6.04255,"twenty":-2.767838,"median":-1.772652,"eighty":-1.048985,"marketCap":106542242},{"date":"2024-08-23","current":7.264821,"twenty":-2.751159,"median":-1.76595,"eighty":-1.035677,"marketCap":128093330},{"date":"2024-08-30","current":6.620716,"twenty":-2.748725,"median":-1.74856,"eighty":-1.010912,"marketCap":116736463},{"date":"2024-09-06","current":6.452522,"twenty":-2.737422,"median":-1.739143,"eighty":-1.002917,"marketCap":113770871},{"date":"2024-09-13","current":6.47928,"twenty":-2.728298,"median":-1.722388,"eighty":-0.962694,"marketCap":114242670},{"date":"2024-09-20","current":6.762152,"twenty":-2.708364,"median":-1.705271,"eighty":-0.946498,"marketCap":119230256},{"date":"2024-09-27","current":6.307264,"twenty":-2.69932,"median":-1.681719,"eighty":-0.931824,"marketCap":111209679},{"date":"2024-10-04","current":6.017703,"twenty":-2.690023,"median":-1.670449,"eighty":-0.912311,"marketCap":106104143},{"date":"2024-10-11","current":5.00663,"twenty":-2.682394,"median":-1.655154,"eighty":-0.892712,"marketCap":88276895},{"date":"2024-10-18","current":4.746694,"twenty":-2.674922,"median":-1.646991,"eighty":-0.878379,"marketCap":83693708},{"date":"2024-10-25","current":4.630105,"twenty":-2.667338,"median":-1.632626,"eighty":-0.872954,"marketCap":81638014},{"date":"2024-10-31","current":4.959803,"twenty":-2.649216,"median":-1.616017,"eighty":-0.858452,"marketCap":87451247},{"date":"2024-11-08","current":5.893469,"twenty":-2.6407,"median":-1.611807,"eighty":-0.830145,"marketCap":103913650},{"date":"2024-11-15","current":-4.172328,"twenty":-2.625186,"median":-1.606893,"eighty":-0.826652,"marketCap":69924052},{"date":"2024-11-22","current":-3.74899,"twenty":-2.625186,"median":-1.606893,"eighty":-0.826652,"marketCap":62829319},{"date":"2024-11-29","current":-3.999329,"twenty":-2.628371,"median":-1.606893,"eighty":-0.826652,"marketCap":67024762},{"date":"2024-12-06","current":-3.958624,"twenty":-2.628371,"median":-1.606893,"eighty":-0.826652,"marketCap":66342576},{"date":"2024-12-13","current":-6.110935,"twenty":-2.628371,"median":-1.606893,"eighty":-0.826652,"marketCap":102413154},{"date":"2024-12-20","current":-6.180134,"twenty":-2.628371,"median":-1.606893,"eighty":-0.826652,"marketCap":103572870},{"date":"2024-12-27","current":-8.199134,"twenty":-2.628371,"median":-1.606893,"eighty":-0.826652,"marketCap":137409290},{"date":"2025-01-03","current":-7.652661,"twenty":-2.628371,"median":-1.606893,"eighty":-0.826652,"marketCap":128250944},{"date":"2025-01-10","current":-6.47525,"twenty":-2.625871,"median":-1.605208,"eighty":-0.826557,"marketCap":108518718},{"date":"2025-01-17","current":-4.693361,"twenty":-2.625871,"median":-1.605208,"eighty":-0.826557,"marketCap":78656031},{"date":"2025-01-24","current":-5.269345,"twenty":-2.625871,"median":-1.605208,"eighty":-0.826557,"marketCap":88308961},{"date":"2025-01-31","current":-6.737802,"twenty":-2.628817,"median":-1.605208,"eighty":-0.826557,"marketCap":112918817},{"date":"2025-02-07","current":-5.598044,"twenty":-2.643537,"median":-1.605208,"eighty":-0.826557,"marketCap":93817612},{"date":"2025-02-14","current":-5.114664,"twenty":-2.643537,"median":-1.605208,"eighty":-0.826557,"marketCap":85716655},{"date":"2025-02-21","current":-4.817513,"twenty":-2.643537,"median":-1.605208,"eighty":-0.826557,"marketCap":80736698},{"date":"2025-02-28","current":-3.760184,"twenty":-2.643537,"median":-1.605208,"eighty":-0.826557,"marketCap":63016920},{"date":"2025-03-07","current":-3.817172,"twenty":-2.641917,"median":-1.603523,"eighty":-0.826462,"marketCap":63971980},{"date":"2025-03-14","current":-3.221852,"twenty":-2.646201,"median":-1.603523,"eighty":-0.826462,"marketCap":53995012},{"date":"2025-03-21","current":-3.097699,"twenty":-2.662384,"median":-1.603523,"eighty":-0.826462,"marketCap":51914345},{"date":"2025-03-28","current":-1.257139,"twenty":-2.656442,"median":-1.594804,"eighty":-0.826462,"marketCap":47079870},{"date":"2025-04-04","current":-0.973808,"twenty":-2.646919,"median":-1.575893,"eighty":-0.826462,"marketCap":36469098},{"date":"2025-04-11","current":-0.981227,"twenty":-2.641308,"median":-1.559897,"eighty":-0.826557,"marketCap":36746958},{"date":"2025-04-17","current":-0.905641,"twenty":-2.622906,"median":-1.547071,"eighty":-0.826557,"marketCap":33916262},{"date":"2025-04-25","current":-0.86808,"twenty":-2.60442,"median":-1.53604,"eighty":-0.826462,"marketCap":32509596},{"date":"2025-05-02","current":-0.579647,"twenty":-2.591142,"median":-1.526137,"eighty":-0.821919,"marketCap":21707775},{"date":"2025-05-09","current":1.304615,"twenty":-2.568194,"median":-1.51798,"eighty":-0.812114,"marketCap":19044776},{"date":"2025-05-16","current":1.19755,"twenty":-2.558093,"median":-1.50025,"eighty":-0.800379,"marketCap":17481831},{"date":"2025-05-23","current":1.280823,"twenty":-2.544754,"median":-1.482114,"eighty":-0.791596,"marketCap":18697455},{"date":"2025-05-30","current":1.39582,"twenty":-2.532848,"median":-1.467439,"eighty":-0.782556,"marketCap":20376174},{"date":"2025-06-05","current":1.60202,"twenty":-2.525254,"median":-1.461264,"eighty":-0.774503,"marketCap":23386291}],"updateTime":1749281637796}}}